Dashboard
Manage Tickers

BWAY


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-maintains-buy-on-brainsway-raises-price-target-to-18
HC Wainwright & Co. Maintains Buy on Brain...
11/13/2025 18:01:28

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target ...

the-fda-has-granted-label-expansion-for-brainsways-deep-transcranial-magnetic-stimulation-system-making-the-treatment-available-as-an-adjunct-therapy-for-adolescents-aged-15-to-21-years-suffering-from-major-depressive-disorder
The FDA Has Granted Label Expansion For Br...
11/13/2025 11:06:48

northland-capital-markets-maintains-outperform-on-brainsway-raises-price-target-to-23
Northland Capital Markets Maintains Outper...
11/12/2025 18:07:23

Northland Capital Markets analyst Carl Byrnes maintains BrainsWay (NASDAQ:BWAY) with a Outperform and raises the price targe...

brainsway-raises-fy2025-sales-guidance-from-50000m-52000m-to-51000m-52000m
BrainsWay Raises FY2025 Sales Guidance fro...
11/11/2025 12:31:40

BrainsWay (NASDAQ:BWAY) raises FY2025 sales outlook from $50.000 million-$52.000 million to $51.000 million-$52.000 million.

brainsway-q3-eps-004-misses-007-estimate-sales-13512m-beat-13041m-estimate
BrainsWay Q3 EPS $0.04 Misses $0.07 Estima...
11/11/2025 12:30:47

BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 by ...

earnings-scheduled-for-november-11-2025
Earnings Scheduled For November 11, 2025
11/11/2025 11:11:20

insights-into-brainsways-upcoming-earnings
Insights into BrainsWay's Upcoming Earnings
11/10/2025 15:03:35

brainsway-awarded-25m-grant-from-us-nih-to-support-clinical-trial-evaluating-deep-transcranial-magnetic-stimulation-protocol-through-brainsways-device-for-alcohol-use-disorder-treatment
BrainsWay Awarded $2.5M Grant From U.S. NI...
11/04/2025 13:09:23

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasiv...

brainsway-announces-strategic-investment-in-heading-health-commits-up-to-4m-to-expand-mental-health-clinic-network
BrainsWay Announces Strategic Investment I...
10/27/2025 11:46:56

Recent agreements with two additional U.S. mental health providers bring total to four in 2025Strategy seeks to drive long-term...

brainsway-announces-fda-granted-expansion-of-cleared-treatment-protocols-for-the-companys-deep-tms-to-include-accelerated-protocol-for-major-depressive-disorder
BrainsWay Announces FDA Granted Expansion ...
09/16/2025 12:33:12

hc-wainwright--co-reiterates-buy-on-brainsway-maintains-17-price-target
HC Wainwright & Co. Reiterates Buy on Brai...
08/25/2025 11:03:05

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $17 price tar...

brainsway-announces-strategic-investment-in-neurolief-ahead-of-fda-approval-and-commercial-launch-of-proliv-rx-for-major-depressive-disorder
BrainsWay Announces Strategic Investment I...
08/21/2025 13:34:33

 Neurolief, a pioneering brain stimulation company specializing in non-invasive neuromodulation therapies, today announced a st...

brainsway-invests-23m-in-axis-mental-health-clinics-with-option-for-1m-more
BrainsWay Invests $2.3M In Axis Mental Hea...
08/20/2025 11:38:37

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasiv...

breaking-down-brainsway-4-analysts-share-their-views
Breaking Down BrainsWay: 4 Analysts Share ...
08/14/2025 19:01:33

northland-capital-markets-maintains-outperform-on-brainsway-raises-price-target-to-19
Northland Capital Markets Maintains Outper...
08/14/2025 18:05:37

Northland Capital Markets analyst Carl Byrnes maintains BrainsWay (NASDAQ:BWAY) with a Outperform and raises the price targe...

hc-wainwright--co-maintains-buy-on-brainsway-raises-price-target-to-17
HC Wainwright & Co. Maintains Buy on Brain...
08/14/2025 11:24:04

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target ...

brainsway-raises-fy2025-sales-guidance-from-49000m-51000m-to-50000m-52000m
BrainsWay Raises FY2025 Sales Guidance fro...
08/13/2025 11:32:29

BrainsWay (NASDAQ:BWAY) raises FY2025 sales outlook from $49.000 million-$51.000 million to $50.000 million-$52.000 million.

brainsway-q2-eps-005-inline-sales-12632m-beat-12357m-estimate
BrainsWay Q2 EPS $0.05, Inline, Sales $12....
08/13/2025 11:32:03

BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.05 per share which met the analyst consensus estimate. This is a 150 ...

Core News & Articles
Earnings Scheduled For August 13, 2025
08/13/2025 08:32:30

hc-wainwright--co-reiterates-buy-on-brainsway-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Brai...
06/12/2025 11:08:13

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $16 price tar...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION